Cardiovascular Diseases in the Silesian Region in Poland.
NCT ID: NCT02743533
Last Updated: 2017-04-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
10000000 participants
OBSERVATIONAL
2006-01-31
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The data include information on all the applicable diagnostic and therapeutic procedures, prognosis and hospitalization costs. Likewise, data have been collected specialist care outpatient visits and primary health care patients were hospitalized.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Lower Silesia Cardiogenic Shock Initiative
NCT05465200
Polish Nationwide Registry of Diagnostics, Treatment and Outcome in Patients With Cardiogenic Shock
NCT06697093
Prevention and Treatment of Cardiovascular Disease
NCT06413823
Surgical Removal of Carotid Body in Patients With Systolic Heart Failure
NCT01653821
Prognostic Impact of Sleep Disorders in Patients : Pro-TSIC Study
NCT04653883
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The aim of the study is to collect and analyze all epidemiological data, diagnostic and therapeutic procedures, in-hospital and long-term prognosis, hospitalization costs of these patients. Likewise, data have been collected specialist care outpatient visits and primary health care patients were hospitalized.
For the analysis were included patients hospitalized in the cardiology, cardiac surgery , diabetes, vascular surgery wards and who were hospitalized for cardiac diagnosis in the wards of internal medicine and intensive care.
The Silesian Cardiovascular Database was created based on the agreement between Silesian Centre for Heart Diseases in Zabrze and the Regional Department of National Health Fund in Katowice in order to conduct analyses and prepare scientific elaborations on the group of patients with circulatory system diseases. Data elaboration and preparation for analyses was conducted by the Science Department of Silesian Centre for Heart Diseases and the Department of Biostatistics of Medical University of Silesia.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* hospitalisation with cardiological diagnosis in the departments of internal medicine and intensive care.
Exclusion Criteria
* patients at the age below18 years at the moment of admission to the hospital
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Silesian Centre for Heart Diseases
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mariusz Gasior
Professor, PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mariusz Gasior, Prof., PhD
Role: PRINCIPAL_INVESTIGATOR
3rd Chair and Department of Cardiology, Silesian Center for Heart Diseases, Zabrze, Poland
Damian Pres, MD
Role: STUDY_CHAIR
3rd Chair and Department of Cardiology, Silesian Center for Heart Diseases, Zabrze, Poland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Silesian Center for Heart Diseases
Zabrze, , Poland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Myrda K, Blachut A, Buchta P, Skrzypek M, Wnuk-Wojnar AM, Hoffmann A, Nowak S, Kowalski O, Pruszkowska P, Sokal A, Wita K, Mizia-Stec K, Gasior M, Kalarus Z. Impact of the coronavirus disease 2019 pandemic on atrial fibrillation and atrial flutter ablation rates. The analysis of nearly 5 million Polish population. Kardiol Pol. 2021;79(6):687-689. doi: 10.33963/KP.15988. Epub 2021 May 20. No abstract available.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SCD016
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.